The global Human Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ 115 million in 2023 and is anticipated to reach US$ 365.4 million by 2030, witnessing a CAGR of 18.2% during the forecast period 2024-2030.

Human Induced Pluripotent Stem Cells (iPSCs) Market

Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.

North American market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Human Induced Pluripotent Stem Cells (iPSCs) in Academic Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Human Induced Pluripotent Stem Cells (iPSCs) include FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology and ReproCELL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Induced Pluripotent Stem Cells (iPSCs).

Report Scope

The Human Induced Pluripotent Stem Cells (iPSCs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Induced Pluripotent Stem Cells (iPSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Induced Pluripotent Stem Cells (iPSCs) Market Report

Report Metric	Details
Report Name	Human Induced Pluripotent Stem Cells (iPSCs) Market
Accounted market size in 2023	US$ 115 million
Forecasted market size in 2030	US$ 365.4 million
CAGR	18.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Skin Blood Others
Segment by Application	Academic Research Drug Development and Discovery Toxicity Screening Regenerative Medicine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology, ReproCELL, AcceGen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Induced Pluripotent Stem Cells (iPSCs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Induced Pluripotent Stem Cells (iPSCs) Market growing?

Ans: The Human Induced Pluripotent Stem Cells (iPSCs) Market witnessing a CAGR of 18.2% during the forecast period 2024-2030.

What is the Human Induced Pluripotent Stem Cells (iPSCs) Market size in 2030?

Ans: The Human Induced Pluripotent Stem Cells (iPSCs) Market size in 2030 will be US$ 365.4 million.

Who are the main players in the Human Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The main players in the Human Induced Pluripotent Stem Cells (iPSCs) Market are FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology, ReproCELL, AcceGen

What are the Application segmentation covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Applications covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report are Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others

What are the Type segmentation covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Types covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report are Skin, Blood, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Skin

1.2.3 Blood

1.2.4 Others

1.3 Market by Application

1.3.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Academic Research

1.3.3 Drug Development and Discovery

1.3.4 Toxicity Screening

1.3.5 Regenerative Medicine

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2019-2030)

2.2 Human Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region

2.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Region (2019-2024)

2.2.3 Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2025-2030)

2.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Dynamics

2.3.1 Human Induced Pluripotent Stem Cells (iPSCs) Industry Trends

2.3.2 Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers

2.3.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges

2.3.4 Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Revenue

3.1.1 Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2019-2024)

3.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2024)

3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Human Induced Pluripotent Stem Cells (iPSCs) Revenue

3.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio

3.4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023

3.5 Human Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served

3.6 Key Players Human Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service

3.7 Date of Enter into Human Induced Pluripotent Stem Cells (iPSCs) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type

4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2019-2024)

4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2025-2030)

5 Human Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application

5.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2019-2024)

5.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)

6.2 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)

6.4 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)

7.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)

7.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)

8.2 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024)

8.4 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)

9.2 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)

9.4 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)

10.2 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)

10.4 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 FUJIFILM Cellular Dynamics

11.1.1 FUJIFILM Cellular Dynamics Company Detail

11.1.2 FUJIFILM Cellular Dynamics Business Overview

11.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.1.4 FUJIFILM Cellular Dynamics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.1.5 FUJIFILM Cellular Dynamics Recent Development

11.2 Takara Bio

11.2.1 Takara Bio Company Detail

11.2.2 Takara Bio Business Overview

11.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.2.4 Takara Bio Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.2.5 Takara Bio Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Detail

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.3.4 Thermo Fisher Scientific Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Ncardia

11.4.1 Ncardia Company Detail

11.4.2 Ncardia Business Overview

11.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.4.4 Ncardia Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.4.5 Ncardia Recent Development

11.5 Sumitomo Dainippon Pharma

11.5.1 Sumitomo Dainippon Pharma Company Detail

11.5.2 Sumitomo Dainippon Pharma Business Overview

11.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.5.4 Sumitomo Dainippon Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.5.5 Sumitomo Dainippon Pharma Recent Development

11.6 Astellas Pharma

11.6.1 Astellas Pharma Company Detail

11.6.2 Astellas Pharma Business Overview

11.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.6.4 Astellas Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.6.5 Astellas Pharma Recent Development

11.7 Fate Therapeutics

11.7.1 Fate Therapeutics Company Detail

11.7.2 Fate Therapeutics Business Overview

11.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.7.4 Fate Therapeutics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.7.5 Fate Therapeutics Recent Development

11.8 Cell Inspire Biotechnology

11.8.1 Cell Inspire Biotechnology Company Detail

11.8.2 Cell Inspire Biotechnology Business Overview

11.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.8.4 Cell Inspire Biotechnology Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.8.5 Cell Inspire Biotechnology Recent Development

11.9 ReproCELL

11.9.1 ReproCELL Company Detail

11.9.2 ReproCELL Business Overview

11.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.9.4 ReproCELL Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.9.5 ReproCELL Recent Development

11.10 AcceGen

11.10.1 AcceGen Company Detail

11.10.2 AcceGen Business Overview

11.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Introduction

11.10.4 AcceGen Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

11.10.5 AcceGen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Fujifilm Cellular Dynamics

Takara Bio

Thermo Fisher Scientific

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma

Fate Therapeutics

Cell Inspire Biotechnology

Reprocell

AcceGen

List of Tables

Table 1. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Skin

Table 3. Key Players of Blood

Table 4. Key Players of Others

Table 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2019-2024)

Table 9. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2025-2030)

Table 11. Human Induced Pluripotent Stem Cells (iPSCs) Market Trends

Table 12. Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers

Table 13. Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges

Table 14. Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints

Table 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2019-2024)

Table 17. Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2023)

Table 18. Ranking of Global Top Human Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Human Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service

Table 22. Date of Enter into Human Induced Pluripotent Stem Cells (iPSCs) Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2019-2024)

Table 26. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2025-2030)

Table 28. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2019-2024)

Table 30. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2025-2030)

Table 32. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)

Table 47. FUJIFILM Cellular Dynamics Company Detail

Table 48. FUJIFILM Cellular Dynamics Business Overview

Table 49. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 50. FUJIFILM Cellular Dynamics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 51. FUJIFILM Cellular Dynamics Recent Development

Table 52. Takara Bio Company Detail

Table 53. Takara Bio Business Overview

Table 54. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 55. Takara Bio Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 56. Takara Bio Recent Development

Table 57. Thermo Fisher Scientific Company Detail

Table 58. Thermo Fisher Scientific Business Overview

Table 59. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 60. Thermo Fisher Scientific Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 61. Thermo Fisher Scientific Recent Development

Table 62. Ncardia Company Detail

Table 63. Ncardia Business Overview

Table 64. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 65. Ncardia Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 66. Ncardia Recent Development

Table 67. Sumitomo Dainippon Pharma Company Detail

Table 68. Sumitomo Dainippon Pharma Business Overview

Table 69. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 70. Sumitomo Dainippon Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 71. Sumitomo Dainippon Pharma Recent Development

Table 72. Astellas Pharma Company Detail

Table 73. Astellas Pharma Business Overview

Table 74. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 75. Astellas Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 76. Astellas Pharma Recent Development

Table 77. Fate Therapeutics Company Detail

Table 78. Fate Therapeutics Business Overview

Table 79. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 80. Fate Therapeutics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 81. Fate Therapeutics Recent Development

Table 82. Cell Inspire Biotechnology Company Detail

Table 83. Cell Inspire Biotechnology Business Overview

Table 84. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 85. Cell Inspire Biotechnology Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 86. Cell Inspire Biotechnology Recent Development

Table 87. ReproCELL Company Detail

Table 88. ReproCELL Business Overview

Table 89. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 90. ReproCELL Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 91. ReproCELL Recent Development

Table 92. AcceGen Company Detail

Table 93. AcceGen Business Overview

Table 94. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product

Table 95. AcceGen Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)

Table 96. AcceGen Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2023 VS 2030

Figure 3. Skin Features

Figure 4. Blood Features

Figure 5. Others Features

Figure 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2023 VS 2030

Figure 8. Academic Research Case Studies

Figure 9. Drug Development and Discovery Case Studies

Figure 10. Toxicity Screening Case Studies

Figure 11. Regenerative Medicine Case Studies

Figure 12. Others Case Studies

Figure 13. Human Induced Pluripotent Stem Cells (iPSCs) Report Years Considered

Figure 14. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region: 2023 VS 2030

Figure 17. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2023

Figure 18. Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023

Figure 20. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)

Figure 22. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)

Figure 26. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2019-2030)

Figure 34. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)

Figure 42. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)

Figure 46. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. FUJIFILM Cellular Dynamics Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 49. Takara Bio Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 51. Ncardia Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 52. Sumitomo Dainippon Pharma Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 53. Astellas Pharma Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 54. Fate Therapeutics Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 55. Cell Inspire Biotechnology Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 56. ReproCELL Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 57. AcceGen Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stem Cell Culture Medium Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0Z11199

Wed May 08 00:00:00 UTC 2024

Add to Cart

Global Methylphenidate Transdermal Patches Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0Y12011

Wed May 08 00:00:00 UTC 2024

Add to Cart

Global Patent Foramen Ovale (PFO) Closure Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10C11626

Mon May 06 00:00:00 UTC 2024

Add to Cart

Global Diabetes Care Intelligence Center Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13A11356

Mon May 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions